Drug intelligence / Profile preview

huzhang qingmai yin

Development stage
Preclinical
Administration
Oral
01

Overview

Huzhang Qingmai Yin (虎杖清脉饮) is a traditional Chinese medicine (TCM) compound formula developed by Professor Xi Jiuyi, a renowned vascular disease expert in Shanghai. It is used clinically for conditions classified as "heat stagnation and toxin accumulation with obstructed collaterals" in TCM, particularly for cerebral small vessel disease and chronic cerebral ischemia. The formula is reported to improve cognitive function and modulate gut microbiota diversity in animal models of chronic cerebral ischemia[1][2]. Its mechanism involves regulating the abundance of specific gut bacteria genera such as Akkermansia, Coprobacillus, Parabacteroides, Erysipelatoclostridium, Turicibacter, Allobaculum, and Eubacterium_xylanophilum_group[1]. The main herbal ingredient is Polygonum cuspidatum (虎杖), known for its anti-inflammatory, antioxidant, antithrombotic effects and ability to improve microcirculation[3][4][5]. Huzhang Qingmai Yin acts through multiple pharmacological pathways including anti-inflammation and vascular protection.

Brand names
虎杖清脉饮
Other names
huzhang qingmai decoction虎杖清脉饮
02

Targets

JUN (Transcription factor Jun)STAT3 (Signal Transducer and Activator of Transcription 3)

Beyond the preview

Go deeper on huzhang qingmai yin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on huzhang qingmai yin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call